NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the fourth quarter and full year 2024 and introduced full year 2025 guidance for Portfolio Receipts.
Royalty Pharma Reports Q4 and Full Year 2024 Results
Seeking Alpha / 1 minute from now 1 Views
Comments